Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-22T14:45:09.590Z Has data issue: false hasContentIssue false
  • English
  • Français

Potential value for new diagnostic markers in the early recognition of acute coronary syndromes

Published online by Cambridge University Press:  21 May 2015

Giuseppe Lippi ,
Martina Montagnana ,
Gian Luca Salvagno  and
Gian Cesare Guidi
Giuseppe Lippi*
Affiliation:
Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitá degli Studi di Verona, Verona, Italy
Martina Montagnana
Affiliation:
Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitá degli Studi di Verona, Verona, Italy
Gian Luca Salvagno
Affiliation:
Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitá degli Studi di Verona, Verona, Italy
Gian Cesare Guidi
Affiliation:
Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitá degli Studi di Verona, Verona, Italy
*
Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitá degli Studi di Verona, Ospedale Policlinico G.B. Rossi, Piazzale Scuro, 10, 37134 - Verona, Italy; tel 0093-045-8074516, fax 0039-045-8201889, [email protected]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The diagnostic approach to acute coronary syndromes (ACS) remains one of the most difficult and controversial challenges facing emergency physicians. In recent years, cardiac troponins have emerged as the biochemical “gold standard” for diagnosis of patients with acute chest pain, enhancing our ability to recognize ACS. Early diagnosis and treatment of myocardial ischemia improve patient outcomes, but conventional markers are often nondiagnostic at the time of arrival at the emergency department. Promising new biomarkers, which appear earlier after the onset of ischemia, are being studied and integrated into clinical practice. Some are markers of myocyte necrosis, but others, including ischemia-modified albumin and natriuretic peptides, detect myocardial ischemia and myocardial dysfunction. The aim of the present article is to review the diagnostic approach to ACS, focusing on recent literature describing novel biochemical markers. If ongoing and future studies confirm their role in probability-based models risk assessment, a new era in the diagnostic approach to ACS may be dawning.

Keywords

acute coronary syndromesacute myocardial infarctionischemia modified albuminlaboratory biomarkersmyocardial ischemiabrain natriuretic peptide
Type
Education • Éducation
Information
Canadian Journal of Emergency Medicine , Volume 8 , Issue 1 , January 2006 , pp. 27 - 31
Copyright
Copyright © Canadian Association of Emergency Physicians 2006

References

1.Lampe, FC, Morris, RW, Walker, M, et al. Trends in rates of different forms of diagnosed coronary heart disease, 1978 to 2000: prospective, population based study of British men. BMJ 2005;330:1046.CrossRefGoogle ScholarPubMed
2.Rosalki, SB, Roberts, R, Katus, HA, et al. Cardiac biomarkers for detection of myocardial infarction: perspectives from fast to present. Clin Chem 2004;50:2205–13.Google Scholar
3.Fox, KAA, Birkhead, J, Wilcox, R, et al. British Cardiac Society Working Group on the definition ofmyocardial infarction. Heart 2004;90:603–9.CrossRefGoogle Scholar
4.Karras, DJ, Kane, DL. Serum markers in the emergency department diagnosis of acute myocardial infarction. Emerg Med Clin North Am 2001;19:321–37.CrossRefGoogle ScholarPubMed
5.Ryan, TJ, Antman, EM, Brooks, NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Committee on Management of Acute Myocardial Infarction. J Am Coll Cardiol 1999;334:890–911.CrossRefGoogle Scholar
6.Ohman, EM, Casey, C, Bengtson, JR, et al. Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation. Br Heart J 1990;63:335–8.CrossRefGoogle ScholarPubMed
7.French, JK, White, HD. Clinical implications of the new definition of myocardial infarction. Heart 2004;90:99–106.Google Scholar
8.Panteghini, M. Role and importance of biochemical markers in clinical cardiology. Eur Heart J 2004;25:1187–96.Google Scholar
9.Myocardial Infarction Redefined — A Consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial In-farction. J Am Coll Cardiol 2000;36:959–68.CrossRefGoogle Scholar
10.Penttila, I, Penttila, K, Rantanen, T. Laboratory diagnosis of patients with acute chest pain. Clin Chem Lab Med 2000;38:187–97.Google Scholar
11.Wu, AH. Analytical and clinical evaluation of new diagnostic tests for myocardial damage. Clin Chim Acta 1998;272:11–21.CrossRefGoogle ScholarPubMed
12.Fitchett, D, Goodman, S, Langer, A. New advances in the management of acute coronary syndromes: 1. Matching treatment to risk. CMAJ 2001;164:1309–16.Google ScholarPubMed
13.Singh, SM, Alter, DA. Is routine early invasive management of non-ST-segment elevation myocardial infarction beneficial in elderly patients? CMAJ 2004;171:1046–7.Google Scholar
14.Christenson, J, Innes, G, McKnight, D, et al. Safety and efficiency of emergency department assessment of chest discomfort. CMAJ 2004;170:1803–7.CrossRefGoogle ScholarPubMed
15.Fuster, V, Badimon, L, Badimon, JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1) [review]. N Engl J Med 1992;326(4):242–50.Google Scholar
16.Fuster, V, Badimon, L, Badimon, JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2) [review]. N Engl J Med 1992;326(5):310–8.Google Scholar
17.Perers, E, Caidahl, K, Herlitz, J, et al. Spectrum of acute coronary syndromes: history and clinical presentation in relation to sex and age. Cardiology 2004;102:67–76.CrossRefGoogle ScholarPubMed
18.Galvani, M, Ferrini, D,Ghezzi, F, et al. Cardiac markers and risk stratification: an integrated approach. Clin Chim Acta 2001;311:9–17.Google Scholar
19.Menown, IB, Mathew, TP, Gracey, HM, et al. Prediction of Recurrent Events by D-Dimer and Inflammatory Markers in Patients with Normal Cardiac Troponin I (PREDICT) Study. Am Heart J 2003;145:986–92.CrossRefGoogle ScholarPubMed
20.Christenson, RH, Duhq, SH, Sanhai, WR, et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464–70.CrossRefGoogle ScholarPubMed
21.Roy, D, Quiles, J, Aldama, G, et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004;97:297–301.Google Scholar
22.Roy, D, Quiles, J, Sharma, R, et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise induced skeletal muscle ischemia. Clin Chem 2004;50:1656–60.CrossRefGoogle ScholarPubMed
23.Anwaruddin, S, Januzzi, JL Jr, Baggish, AL, et al. Ischemia-modified albumin improves the usefulness of standard cardiac bio-markers for the diagnosis of myocardial ischemia inthe emergency department setting. Am J Clin Pathol 2005;123:140–5.Google Scholar
24.Gidenne, S, Ceppa, F, Fontan, E, et al. Analytical performance of the Albumin Cobalt Binding (ACB)test on the Cobas MIRA Plus analyzer. Clin Chem Lab Med 2004;42:455–61.Google Scholar
25.Lippi, G, Montagnana, M, Guidi, GC. Albumin cobalt binding and ischemia modified albumin generation: An endogenous response to ischemia? Int J Cardiol. In press.Google Scholar
26.deFilippi, C, Yoon, S, Ro, A. Early detection of myocardial ischemia by a novel blood based biomarker: the kineticsof ischemia modified albumin. J Am Coll Cardiol 2003;41:6(supplA):340A.CrossRefGoogle Scholar
27.Lippi, G, Mengoni, A, Manzato, F. Plasma D-dimer in the diagnosis of deep vein thrombosis. JAMA 1998;280:1828–9.CrossRefGoogle ScholarPubMed
28.Zapico-Muniz, E, Santalo-Bel, M, Merce-Muntanola, J, et al. Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem 2004;50:1065.Google Scholar
29.Bayes-Genis, A, Conover, CA, Overgaard, MT, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001;345:1022–9.CrossRefGoogle ScholarPubMed
30.Heeschen, C, Dimmeler, S, Hamm, CW, et al. CAPTURE Study Investigators: Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005;45:229–37.Google Scholar
31.Januzzi, JL Jr, Camargo, CA, Anwaruddin, S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005;95:948–54.CrossRefGoogle ScholarPubMed
32.Kragelund, C, Gronning, B, Kober, L, et al. N-terminal pro-B-type natriuretic peptide andlong-termmortality in stable coronary heart disease. N Engl J Med 2005;352:666–75.Google Scholar
33.Bassan, R, Potsch, A, Maisel, A, et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005;26:234–40.CrossRefGoogle ScholarPubMed
34.Bettencourt, P, Azevedo, A, Pimenta, J, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168–74.CrossRefGoogle ScholarPubMed
35.Borgundvaag, B. Your cheatin’ heart [editorial]. Can J Emerg Med 2003;5(2):124–6.CrossRefGoogle ScholarPubMed